politics
Administration Considers Pilot Program for 340B Drug Discount Transparency
The Trump administration is evaluating a pilot program to increase oversight of the 340B drug discount program. The program requires drug manufacturers to sell medicines at reduced prices to hospitals and clinics that serve low-income patients.
forbes.comAudio version
Tap play to generate a narrated version.
Developing·Limited corroboration so far. This page will refresh as more sources emerge.
The Trump administration is considering a pilot program that could bring additional transparency to the 340B drug discount program. The program was created by Congress to help hospitals and clinics serving low-income patients provide medications at discounted rates.
Under the program, drug manufacturers provide medicines at steep discounts, which providers are supposed to pass on to vulnerable patients.
Hospitals have opposed efforts to require greater reporting on how the discounts are used.
Transparency
How sources framed this
Single source — no framing comparison available.
CorroborationLimited · 1 source
